Investor Relations

Latest News

Dec 1, 2020

MPX International's Wholly-Owned Subsidary, Canveda Inc., Receives Licence Amendment From Health Canada Authorizing Production and Sales of Cannabis 2.0 Products

View Press Release

Nov 19, 2020

MPX International’s Wholly-owned Subsidiary, Canveda Inc., Completes First Transaction Under its Agreement for the Manufacturing and Distribution of Cannabis Products in Israel

Oct 21, 2020

MPX International Announces Closing of the Fourth and Final Tranche of Non-Brokered Private Placement Offering

View All News

Investor Presentation

View Presentation

Fourth Quarter 2019 Earnings Conference Call

Jan 29, 2020 • 8:30 am EST

View Event View All

Company Overview

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

View Management Team View Board of Directors

Investor Contact Information

Company

MPX International Corporation
5255 Yonge Street
Suite 701
Toronto, ON M2N 6P4
Canada
T: 416-840-3725
info@mpxinternationalcorp.com